Matches in Wikidata for { <http://www.wikidata.org/entity/Q90941831> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q90941831 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90941831 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90941831 description "scientific article published on 24 October 2019" @default.
- Q90941831 description "wetenschappelijk artikel" @default.
- Q90941831 description "наукова стаття, опублікована 24 жовтня 2019" @default.
- Q90941831 name "Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions" @default.
- Q90941831 name "Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions" @default.
- Q90941831 type Item @default.
- Q90941831 label "Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions" @default.
- Q90941831 label "Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions" @default.
- Q90941831 prefLabel "Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions" @default.
- Q90941831 prefLabel "Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions" @default.
- Q90941831 P1433 Q90941831-534C610E-F74C-4319-843E-F6F8341E7205 @default.
- Q90941831 P1476 Q90941831-EDED8D49-6ED5-45BD-9A5B-3820B37E3064 @default.
- Q90941831 P304 Q90941831-C1D9453B-79C8-442F-A5A9-48FC5A4CC2D7 @default.
- Q90941831 P31 Q90941831-CE2CE049-047D-45EA-BD03-B03F3B5997F0 @default.
- Q90941831 P356 Q90941831-E732B0CE-7335-464E-B4BD-45B409D15836 @default.
- Q90941831 P433 Q90941831-47DFB701-C7A3-45F2-9393-BA30D248DC78 @default.
- Q90941831 P478 Q90941831-98FADFF9-A74C-409A-A7FC-0F174CC619A4 @default.
- Q90941831 P50 Q90941831-1277D03B-F45D-42C1-8109-84BB8DE07702 @default.
- Q90941831 P50 Q90941831-34D41C8B-03E1-4234-B763-C8D88701A08A @default.
- Q90941831 P50 Q90941831-3EE92FBD-1C29-4107-965D-FACFF85DB688 @default.
- Q90941831 P50 Q90941831-657C5D12-EF96-40EC-9D5E-6D0C6A468AC2 @default.
- Q90941831 P50 Q90941831-A126E2DA-A338-4319-A0DD-52000D68B138 @default.
- Q90941831 P50 Q90941831-BE00ED99-58A9-43AD-B2F4-A1FDB5503D74 @default.
- Q90941831 P50 Q90941831-D3C47881-DBA1-4AC4-ACDC-1FEE12774A34 @default.
- Q90941831 P50 Q90941831-FE47F80D-DD56-4284-89C9-2964A175A82B @default.
- Q90941831 P577 Q90941831-66CD6F91-6049-4ED9-B519-B90F218AF41E @default.
- Q90941831 P698 Q90941831-2EDB4CC6-B995-48C2-9664-3850CAB721AC @default.
- Q90941831 P921 Q90941831-20AA3143-CA8A-476B-946D-3447E0CCD0AC @default.
- Q90941831 P921 Q90941831-F8AF7162-1D9D-4CD8-B08D-8CD97415D503 @default.
- Q90941831 P932 Q90941831-218DC4DE-FFE4-4AF2-898B-07BFC6F04301 @default.
- Q90941831 P356 SAG-1901-15 @default.
- Q90941831 P698 31652041 @default.
- Q90941831 P1433 Q15764699 @default.
- Q90941831 P1476 "Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions" @default.
- Q90941831 P304 "1582-1589" @default.
- Q90941831 P31 Q13442814 @default.
- Q90941831 P356 "10.3906/SAG-1901-15" @default.
- Q90941831 P433 "5" @default.
- Q90941831 P478 "49" @default.
- Q90941831 P50 Q84906291 @default.
- Q90941831 P50 Q90138945 @default.
- Q90941831 P50 Q90941814 @default.
- Q90941831 P50 Q90941817 @default.
- Q90941831 P50 Q90941819 @default.
- Q90941831 P50 Q90941821 @default.
- Q90941831 P50 Q90941824 @default.
- Q90941831 P50 Q90941827 @default.
- Q90941831 P577 "2019-10-24T00:00:00Z" @default.
- Q90941831 P698 "31652041" @default.
- Q90941831 P921 Q410074 @default.
- Q90941831 P921 Q411114 @default.
- Q90941831 P932 "7018237" @default.